Evaluating Motion Style Acupuncture for Upper Extremity Pain Relief
The Effect of Early MSAT Treatment on Radiating Pain in the Upper Extremity Caused by Traffic Accidents: A Pragmatic Randomized Controlled Trial
This study is testing if a new type of acupuncture can help people with arm pain from traffic accidents feel better when combined with regular medical treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 19 Years to 69 Years |
| Sex | All |
| Sponsor | Jaseng Medical Foundation Academic / other |
| Locations | 1 site (Seoul, Gangnam-Gu) |
| Trial ID | NCT06086899 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the efficacy and safety of Motion Style Acupuncture Treatment (MSAT) for patients experiencing radiating pain in the upper extremity following traffic accidents. The study is designed as a double-blind, randomized controlled trial involving 100 hospitalized patients who will be divided into two groups: one receiving MSAT along with standard Korean medical treatment, and the other receiving only standard treatment. The trial aims to assess pain relief and functional improvement using various scales, including the Numeric Rating Scale (NRS) and Visual Analogue Scale (VAS), over a treatment period from October 2023 to December 2024.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients aged 19-69 who have experienced radiating pain in the upper extremity within three days of a traffic accident and have a pain score of 5 or higher.
Not a fit: Patients with serious underlying conditions causing radiating pain, such as malignancies or recent cervical surgeries, may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improved mobility for patients suffering from upper extremity pain due to acute injuries.
How similar studies have performed: While the specific approach of MSAT is novel, similar acupuncture techniques have shown promise in treating pain, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 19-69 years on the date they sign the consent form. * Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident. * Patients who are hospitalized due to traffic accident. * Patients with NRS of radiating pain ≥ 5. * Patients who provide consent to participate in the trial and return the informed consent form. Exclusion Criteria: * Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients with progressive neurological deficits or with severe neurological symptoms. * Patients with medical history of cervical surgery or thoracic surgery within the last three weeks. * Patients who have radiating pain in upper extremity before the traffic accident. * Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study. * If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease. * Patients who are pregnant or planning to become pregnant. * Patients who are participated in clinical trials other than observational studies without therapeutic intervention. * Patients who are difficult to complete the research participation agreement. * Other patients whose participation in the trial is judged by a researcher to be problematic.
Where this trial is running
Seoul, Gangnam-Gu
- Jaseng Hospital of Korean Medicine — Seoul, Gangnam-Gu, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: In-Hyuk Ha, phD — Jaseng Medical Foundation
- Study coordinator: In-Hyuk Ha, phD
- Email: hanitata@jaseng.co.kr
- Phone: 02-2222-2740
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.